We have produced a small antimicrobial peptide PFWRIRIRR in bacteria utilizing production in the form of insoluble fusion protein with ketosteroid isomerase. The recombinant peptide was rapidly and efficiently isolated by acidic cleavage of the fusion protein based on the acid labile Asp-Pro bond at the N-terminus of the peptide. The peptide has antibacterial activity and neutralizes macrophage activation by LPS. The selectivity of the peptide against bacteria correlates with preferential binding to acidic phospholipid vesicles. Solution structure of the peptide in SDS and DPC micelles was determined by NMR. The peptide adopts a well-defined structure, comprising a short helical segment. Cationic and hydrophobic clusters are segregated along the molecular axis of the short helix, which is positioned perpendicular to the membrane plane. The position of the helix is shifted in two micellar types and more nonpolar surface is exposed in anionic micelles. Overall structure explains the advantageous role of the N-terminal proline residue, which forms an integral part of the hydrophobic cluster.
Introduction
Treatment of bacterial infection with antibiotics is one of the mainstays of medicine [1] . Increasing resistance of virtually all microbes toward common antibiotics is a major health concern. Antimicrobial peptides are present in a variety of organisms where they protect the host from microbial infection. They have been identified in and isolated from a variety of sources including mammals, insects, amphibians, fish, plants, prokaryotes [2, 3] . These peptides are less susceptible to the development of bacterial resistance because they act on the bacterial membrane causing multiple stress through several targets [4] but have minimal toxic and allergic effects to the host [5] . Thus, antimicrobial peptides may potentially be applied in medicine as safe antimicrobial agents due to their activities against bacteria and fungi [6] . Recent studies have shown that many cationic antimicrobial peptides are able to neutralize LPS [7] , block cytokine induction in macrophages and prevent sepsis in animal models. Sepsis due to a Gram-negative bacteria is usually caused by the release of a bacterial outer membrane component, endotoxin (lipopolysaccharide, LPS) [7] .
In order to provide large quantities of these peptides for physiological investigation and clinical trials, efficient production methods are necessary. Short antimicrobial peptides can be efficiently prepared by chemical synthesis, but may still be prohibitively expensive for therapy [8] . As an alternative, recombinant methods permit the production of peptides and proteins in microorganisms. Production of antimicrobial peptides in expression systems, such as bacterial, yeast or insect cells has been reported. Escherichia coli has been used for production of many antimicrobial peptides, e.g. lactoferricin [9] , dermicin [10] , moricidin [11] , defensins [12] [13] [14] and buforin [15] . This biological expression system is also suitable to obtain uniformly or partially isotopically enriched peptides, which are required for structural investigation of the ligand-receptor interaction by NMR spectroscopy and provides additional information on molecular dynamics, improvement of the precision of the determined structures and filtered experiments in the complex systems [16, 17] . However, difficulties have been encountered in expression of antimicrobial peptides because of their cytotoxicity to host cells, sensitivity to proteolytic degradation and low expression level [18] . The expression system with an antimicrobial peptide fused to a partner protein is most effective because of the reduced toxicity against host cells, enhanced product stability and facilitated product recovery [19] . Such fusion proteins generally lack antimicrobial activity if they form insoluble products or interact with carrier protein [20] [21] [22] [23] [24] . The peptide is released from the fusion by chemical or enzymatic cleavage [25] .
For this study we selected the peptide based on the structureactivity development of the peptide LF11 originating from human lactoferrin We have already reported solution structure of LF11 in complex with anionic and zwitterionic amphiphiles [16, [26] [27] [28] , where LF11 adopted a defined and unique fold in the micellar environment. We deleted most of the noncharged polar residues that do not contribute to the favorable interactions with anionic lipids or LPS and exchanged several residues, which increased its antimicrobial activity and neutralization of LPS. One of the key properties of antimicrobial peptides is their ability to differentiate between foreign and host cells, which is defined but by the peptide structure and target membrane properties [29] . Importantly, eukaryotic and bacterial membranes have very different lipid compositions. The membrane of host cells comprises mainly phosphatidylcholine, sphingomyelin and cholesterol, whereas bacterial cells expose negatively charged phospholipids, phosphatidylglycerol, cardiolipin and lipopolysaccharides [30] . As demonstrated before, a high content of arginine and hydrophobic residues is essential for activity against bacterial membranes [31] . Short peptides are devoid of defined tertiary structure but can adopt a defined conformation in the lipid environment.
We have produced and purified a recombinant antimicrobial peptide PFWRIRIRR ("PFR peptide") using ketosteroid isomerase (KSI) as a fusion partner in E. coli. The fusion protein formed insoluble inclusion bodies in bacteria. We engineered a single Asp-Pro acid labile dipeptide between KSI and the PFR peptide, which allowed efficient production and isolation of the recombinant peptide in bacteria. We found that the peptide binds to the anionic but not to zwitterionic lipid vesicles and that the type of lipid mimetics significantly affects the peptide structure and may account for its antibacterial activity.
Materials and methods

Gene construct preparation
Oligonucleotide (5′-phosphate-GATCCGTTCTGGCGTATT CGCATCCGTCGCTGAATG-3′), the encoding peptide sequence, annealed with the corresponding complementary oligonucleotide, was ligated into pET31b (+) expression vector (Novagen) 3′ to the ketosteroid isomerase (KSI) gene using restriction site AlwN I [32] .
Media and culture conditions
For protein expression, the E. coli BL21 (DE3) pLysS (Invitrogen) transformed with pET31b(+) encoding KSI-PFR gene and was grown in TB medium. Fermentation was performed in shake flasks with 100 μg/ml ampicillin at 37°C and 220 rpm. Measuring the optical density at 600 nm monitored cell growth. When cultures reached an OD 600 of 0.8, IPTG at 0.4 mM final concentration was added to the culture broth for induction of the production of recombinant KSI-PFR protein. Four hours after induction, bacteria were harvested by centrifugation at 700 rpm for10 min.
Purification of the expressed proteins
To purify the recombinant proteins, the cell pellet was suspended in the lysis buffer (10 mM Tris pH 8.0, 1 mM EDTA, 0.1% DOC) and lysed by sonication. The bacterial lysate was centrifuged at 12000 rpm for 15 min at 4°C to separate the soluble supernatant and insoluble pellet fraction containing inclusion bodies. The insoluble inclusion body fraction containing KSI-PFR fusion proteins was washed with a series of wash buffers (10 mM Tris pH = 8.0, 1 mM EDTA, 0.1% DOC, twice; 10 mM Tris pH = 8.0, 1 mM EDTA, 0.1% DOC, 2 M urea, twice and with 20 mM Tris pH = 8.0 three times). After every wash the mixture was centrifuged at 12,000 rpm for 10 min at 4°C. The insoluble inclusion bodies were dissolved in 6 M guanidine-HCl and centrifuged. Soluble supernatant dialyzed against deionized water that caused precipitation of KSI-PFR. Fusion proteins were resuspended in 90 mM HCl, the suspension was mixed for 2 h at 85°C to cleave the aspartyl-prolyl bond between the KSI segment and recombinant peptide. The peptide was purified by HPLC on a C5 RP-HPLC column (Supelco) using a gradient of 5% acetonitrile, 5 mM HCl and 95% acetonitrile and 5 mM HCl and freeze dried using repeated washes with water. The peptide peak was detected by UV absorbance at 280 nm. The identity of the peptide peak was determined by mass spectrometry.
Peptide synthesis
The PFR peptide was chemically synthesized by KECK center (Yale University, New Haven, CT, USA) using Fmoc chemistry. The purity of the synthetic peptide was determined by HPLC and MS analysis.
Assay of antimicrobial activity
The antibacterial activity of the purified recombinant PFR was compared to that of the synthetic peptide, using E. coli (NCTC 8007, serotype 0111 K58 H2) that was provided by Prof. Ignacio Moriyon, University of Navarra Pamplona, Spain. Bacterial cultures were stored at −80°C and grown on minimal medium at 37°C. Antimicrobial activity was determined using standard microbroth dilution assay in minimal medium.
Inhibition of NO production in LPS-stimulated RAW264.7 macrophages
The RAW264.7 macrophage cell line was cultured in RPMI supplemented with antibiotic (penicillin 100 IU/ml and streptomycin 100 μg/ml; Gibco) and 12% fetal bovine serum (Perbio) at 37°C under 5% CO 2 . The cell suspension of 1 million cells/well and 100 μM carboxy-PTIO (Sigma) was treated with either LPS (100 ng/ml) alone or with various concentrations of PFR (10-100 μg/ml) for 24 h. Nitric oxide was measured as its end product using Griess reagent (Sigma). The 100 μl culture supernatant from the culture of RAW264.7 cells was mixed with an equal volume of Griess reagent and the absorbance was measured at 570 nm [33] .
Preparation of unilamellar vesicles
Large unilamellar lipid vesicles (LUVs) used for ITC and fluorescence experiments were prepared by extrusion method using a MiniExtruder (Avanti Polar lipids Inc.). The multilamellar vesicle suspension was freeze-thawed for 5 cycles and then extruded 10 times through polycarbonate filters (0.1 μm).
Fluorescence spectroscopy
Tryptophan fluorescence was measured using a Perkin-Elmer LS 55 luminescence spectrometer. Either 1 mM POPG or 1 mM POPC was introduced to 12 μM peptide in PBS. The excitation wavelength used was 295 nm and the emission scanned from 300-450 nm with a scan speed of 300 nm/s. Fluorescence quenching experiments were performed by stepwise addition of acrylamide from stock solution of 1 M into peptide containing solutions in the absence or presence of vesicles at peptide/lipid molar ratio 1:140. Emission spectra, as previously described, were collected after each addition of quencher up to the final acrylamide concentration of 0.5 M. The data were analyzed according to the Stern-Volmer equation,
where F 0 and F are the fluorescence intensities in the absence and the presence of the quencher (Q) and K SV is the Stern-Volmer quenching constant, providing a measure for the accessibility of Trp to acrylamide.
Determination of haemolytic activity
Heparin (4 μl at 5000 IU/ml) was added to 100 μl of fresh peripheral blood from a healthy volunteer and centrifuged at 2000 rpm for 10 min at room temperature. We washed the pellet of red blood cells with phosphate-buffered saline (PBS) and prepared a 2% (vol/vol) suspension of erythrocytes in PBS. Fifty microliters of the peptide in the concentration range from 10 − 6 to 10 − 4 M in PBS and 50 μl of erythrocyte suspension were incubated at 37°C for 1 h. For a positive control, we used 2% (vol/vol) Triton X-100 in PBS, which caused 100% hemolysis. After the incubation, samples were centrifuged for 5 min at 2200 rpm at room temperature, and absorbance at 405 nm was measured.
Isothermal titration calorimetry
ITC data were acquired using a VP-ITC calorimeter (Microcal, LLC). Samples were prepared with 20 μM peptide and either 5 mM POPG or POPC in 10 mM Tris pH 7 and 100 mM NaCl. To account for the heat of dilution titrating the lipid vesicles into a buffered solution in the absence of peptide completed the control experiments. All experiments were carried out at 20°C. Titration was carried out over a 170 min period, with 300 s between individual 5 μl injections.
Nuclear magnetic resonance (NMR) spectroscopy
PFR in SDS sample was prepared by dissolving 1.2 mg of the peptide in 500 μl of sodium phosphate buffer which contained 232 mM D N) Pulse Field Z-Gradient Triple Probe. 2-D homonuclear TOCSY and NOESY spectra were acquired using WET [34] or WATERGATE [35] suppression scheme. TOCSY spectra were recorded at mixing times of 10 and 80 ms. NOESY spectra were recorded at mixing times of 80 and 150 ms. 2048 × 256 data points and spectral widths of 8000 Hz in both dimensions were used with 48 to 128 transients. The HSQC spectrum was acquired with 2048 × 256 data points. WURST80 decoupling was used to remove coupling from NH protons. Spectra were assigned using Felix (Acclerys) software. Calibration of volumes and conversion of volumes into DYANA restraints for upper bounds was achieved using nmr2st program [36] . Two well resolved aromatic proton crosspeaks of I5: HG11-I5: HG12 and I7: HG11-I7: HG12 were used for calibration. The experimental distance constraints were then employed to generate peptide conformers using 6000 steps of simulated annealing in torsion angle space implemented in the program DYANA version 1.5 [37] . 20 structures with the lowest target function out of 100 calculated structures were kept for further minimization. Program DISCOVER (Accelrys) using the cvff force field (21) was used to energy minimize the structures. The quality of structures was checked with PROCHECK_NMR [38] . Structures were visualized and analyzed with MOLMOL [39] .
Results
Production of recombinant antimicrobial peptide in bacteria
Short peptides can be overexpressed in bacteria in the form of fusion proteins, where both bacteria and peptide are protected from membranolytic and proteolytic activity, respectively. The peptide is usually released from the fusion protein by chemical cleavage using CNBr or hydroxylamine, which can however due to their reactivity cause formation of unwanted side products [40] [41] [42] [43] . Therefore we have designed a fusion protein of a PFR peptide with ketosteroid isomerase (KSI-PFR) where we have utilized the acid sensitivity of the Asp-Pro bond engineered at the N-terminus of the peptide. This bond is cleaved in diluted acid at rates at least 100 times more efficient than other peptide bonds. Selective hydrolysis of aspartyl bonds involves intramolecular catalysis by aspartic carboxylate attack of the subsequent carbonyl group with simultaneous donation of a proton to the peptide bond nitrogen and consequent anhydride formation resulting in peptide bond cleavage [40] [41] [42] [43] . The recombinant fusion protein was expressed in high yield in E. coli and accumulated in the form of inclusion bodies. Approximately 550 mg of pure recombinant protein was obtained from 1 l of culture medium. On SDS-PAGE this is seen as a band around the molecular weight of 14 kDa, as expected for the recombinant protein KSI-PFR (Fig. 1). 
Cleavage of the fusion protein at acidic pH
Different conditions were examined to cleave the bond between the fusion protein and recombinant peptide. Fusion protein was treated with 60 to 90 mM HCl for various times to cleave the Asp-Pro bond between the KSI carrier protein and peptide. Alternatively, protein was dissolved in guanidine-HCl acidified by formic acid. The highest amount of the peptide was produced by treatment with 90 mM HCl at 85°C for 2.5 h and decreased afterwards (Fig. 2) . The final yield was 10 mg of purified peptide from 550 mg of recombinant protein per liter of bacterial culture. Following the cleavage, the reaction mixture was purified by HPLC (Fig. 3) . As can be seen, most of the KSI remained insoluble and the peptide represented more than 80% of the material eluted from the column. Mass spectroscopy was used to verify the identity of the purified peptide and its labeling in 15 N isotopically enriched minimal medium (Fig. 4) . Polypeptide backbone of the isotopically labeled peptide has been assigned (data not shown) and will be used to measure interaction of peptide with bacteria and investigate dynamic properties of the peptide.
Biological activity of the peptide
Antimicrobial activity of peptide was examined against E. coli. All tested peptide variants inhibited bacterial growth. The minimal inhibitory concentration for the recombinant peptide was 18 ± 2 μg/ ml in comparison to 6 ± 3 μg/ml and 48 ± 3 μg/ml for the amidated and nonamidated synthetic peptide, respectively. Amidation increased the net charge of the peptide and its affinity to anionic lipids, which is probably the reason for higher antimicrobial activity of amidated peptide. However despite using the same purification procedure and the same MS spectra (Figs. 3 and 4) recombinant peptide was consistently more active than synthetic peptide, probably because of some contaminant from the synthesis although the precise reason could not be determined. Neither recombinant nor synthetic peptides were hemolytic to human erythrocytes up to concentration of 500 μg/ ml. Peptides based on human lactoferrin have previously shown neutralization of bacterial endotoxin, which prevents the cellular activation of macrophages by LPS. To determine the inhibitory effect of the peptide on nitric oxide production in LPS stimulated macrophages, cells were treated with LPS and different concentrations of recombinant peptide. NO production was assayed by measuring nitrite (a stable degradation product of NO) in the supernatant of cultured RAW264.7 cells. Recombinant peptide did not activate the cells, which indicates the absence of LPS contamination and was able to inhibit cell activation by LPS (Fig. 5) . 
Peptide interaction with lipid vesicles
Negatively charged POPG vesicles were used to mimic bacterial membranes and zwitterionic POPC as eukaryotic membrane mimetics. The fluorescence emission spectra of PFR in the presence of POPG and POPC are shown in Fig. 6 . Binding of the peptide to vesicles caused 15 nm blue shift in the emission maximum for POPG vesicles, while the emission maximum of the peptide in the presence of POPC vesicles remained essentially unchanged. Blueshift in the presence of POPG was accompanied by an increase in the fluorescence intensity, consistent with partitioning of the Trp side chain into a more hydrophobic environment [44] . Both amidated and nonamidated peptide displayed a similar effect of different membrane mimetics.
Fluorescence quenching of intrinsic peptide fluorescence in different types of environment
In order to investigate the extent of the exposure of tryptophan residue to the solvent, a fluorescence-quenching study was performed using a neutral quencher acrylamide. In the presence of acrylamide the Trp fluorescence emission of the synthetic PFR peptide in an aqueous buffer decreased in a concentration dependant manner, yielding a Stern-Volmer constant of 28.4 M − 1 (Fig. 7) . In the presence of POPC the K SV decreased to 18.1 M − 1 and further to 6.3 M − 1 for POPG vesicles. A lower K SV indicates a greater degree of protection of the Trp residue and indicates that the fluorophore is inserted into the hydrophobic core of the bilayer. In the case of POPC liposomes the Trp residue was more accessible to the quencher indicating weaker interaction and membrane insertion into the membrane. Amidated peptide however showed an increased degree of protection also in the presence of POPC micelles, which indicates deeper burial of the tryptophan residue within the lipid layer. Described results therefore indicate three different types of environment of the peptide tryptophan residue: it is protected against quenching in both types of lipids (more so in POPG), while as opposed to POPC the Trp side chain is in a more apolar environment in POPG. A likely explanation is that tryptophan inserts into the hydrophobic core of POPG vesicles while burial in case of POPC requires the presence of C-terminal amidation, whereas in case of nonamidated peptide it may only associate with surface headgroup region of POPC vesicles.
Isothermal calorimetric titration of peptide with phospholipid vesicles
The use of ITC provided an opportunity to determine whether the difference in interactions between neutral and negative lipids would be detectable and reflected by isothermal titration calorimetry [44] . The enthalpy of binding was studied by titration of either POPG or POPC vesicles into the peptide solution. The result of the interaction of the peptide to POPC indicated that the energy change was below the sensitivity limit of the technique (data not shown). Binding of the peptide to POPG is shown in Fig. 8 . The binding enthalpy indicates that peptide interaction with POPG vesicles is an exothermic process. Best fit was obtained with two binding site equation yielding K1 = 4.7 ⁎ 10 + 7 in K2 = 4.1 ⁎ 10 + 5 M − 1. Reaction stoichiometry was estimated at a lipid to peptide ratio of 21 and 36 for the first and second step. First step indicates a significant entropic contribution, probably due to the penetration of the peptide into the hydrophobic core of the membrane. Isothermal titration of peptide to lipids has been observed before and has been attributed to membrane processes such as pore formation or membrane disruption have been proposed [45] , although it could also be due to the formation of the second layer of bound peptide at higher peptide:lipid ratios.
3.7. Structure of peptide in micellar environment 3.7.1. Structure of PFR peptide in SDS micelles NMR crosspeak assignments of the most active, synthetic amidated PFR peptide were made using a combination of 2D-TOCSY and 2D-NOESY spectra. Most crosspeaks were resolved in the fingerprint region of the NOESY spectrum except an overlap between Arg 8 and terminal residues form a large hydrophobic surface with large lateral dimension and may thus be able to induce defects when inserted into the bacterial membrane. Arg 4 forms the energetically favorable cation-π interaction with the aromatic group of Trp3, which could facilitate deeper embedding of PFR into anionic membranes. The side chains of Arg 6 , Arg 8 and Arg 9 are positioned around the axis of the short helical segment and point to different directions.
Structure of PFR peptide in DPC micelles
The structure of PFR in the presence of DPC micelles was calculated using 79 distance constraints. PFR structure in DPC is also well defined with a backbone r.m.s.d of 0.38 Å. The backbone also forms one turn of α-helix, which is however in comparison to the SDS structure shifted towards the N-terminus and positioned between residues Phe 2 and Ile 5 (Fig. 11) . The heavy atom r.m.s.d. of hydrophobic residues is 0.68 Å in comparison to overall r.m.s. and Arg 9 in the C-terminal part of the peptide are oriented away from the hydrophobic core. In contrast to the SDS structure there is no energetically favorable Trp-Arg interaction, which has been shown to stabilize the peptide fold in membranes [48] . The comparison between the structure of PFR in SDS and DPC shows that the peptide is in an α-helical conformation between residues 3 and 6 in complex with SDS micelles and between residues 2 and 5 in complex with DPC. The main difference is in the N-terminal hydrophobic segment. , which makes it more compact. This is evident from the higher solvent exposed surface of the structure in SDS (1514 vs.1464 Å 2 ), which is mainly due to the increased nonpolar surface (704 vs. 653 Å 2 ) ( Table 1 ).
Discussion
Peptides are in comparison to most antimicrobials still relatively expensive to produce, which is one of the reasons hindering their application. The high cost of synthetic peptide synthesis and low yield of isolation from the natural host stimulates exploration of recombinant production of antimicrobial peptides [22, 25, 32, [49] [50] [51] . In our study we used KSI as a partner protein that is expressed as an insoluble protein and accumulates in form of inclusion bodies. Most reported antimicrobial peptides were longer than 20 residues, however even recombinant production of a 9-residue peptide resulted in a high yield even without any particular optimization of bacterial fermentation. Normally, fusion proteins are produced in the form of inclusion bodies that can be efficiently solubilized and recombinant fusion proteins are chemically or enzymatically cleaved to release the desired antimicrobial peptide product. Protease cleaves with low efficiency on insoluble protein aggregates, and thus researchers have sought to establish a useful chemical strategy. Previous studies have reported the release of antimicrobial peptides from fusion partners by digestion with CNBr, which can cleave peptides at methionine residues and hydroxylamine which can cleave Asn-Gly peptide linkages [19] . In our system diluted HCl liberated the peptide from the fusion protein at high yield and simplified the isolation procedure. The recombinant peptide consistently exhibited slightly better antimicrobial and endotoxin-neutralizing activity as the synthetic peptide and was indistinguishable by analytical techniques (MS and HPLC), nevertheless additional amidation of the synthetic peptide improved the antimicrobial activity due to the increased affinity for anionic lipids. It has been shown previously that the presence of additional charge may significantly affect the membrane interacting and biological properties of peptides [52] [53] [54] . The selected strategy requires the N-terminal proline residue of the peptide, which is in fact even favorable for the selected peptide. We have shown the essential structural role of the proline residue for the peptide conformation adopted in the membrane mimetic environment. PFR interacts preferentially with negatively charged membranes, which provides its selectivity and high therapeutic index.
The structure of the PFR peptide in SDS and DPC was determined and in both types of micelles the peptide forms a well-defined conformation. The peptide in complex with SDS contains α-helical conformation between residues 3 and 6 and between residues 2 and 5 in complex with DPC. In contrast to most amphipathic α-helical antimicrobial peptides [55] the amphipathic moment lies along the helical axis and not perpendicular to it (Fig. 12) . This can only be accomplished because of the small size of the peptide. Clusters of hydrophobic residues are essential for antimicrobial activity [56] , however a high amount of tryptophan residues increases the nonspecific binding to eukaryotic membrane and hemolytic activity [57, 58] . The PFR peptide contains only a single tryptophan residue and an additional phenylalanine residue, which is responsible for its high specificity for anionic membranes and the absence of haemolytic activity. Alternating Arg-Ile residues in the region 4 to 8 induce formation of a short helical segment in the peptide. Three hydrophobic residues at the N-terminus of the PFR peptide form a cluster, which is more compact in the zwitterionic environment and has a larger lateral dimension in anionic micelles. The difference in the charge distribution of PFR in anionic and zwitterionic micelles as well as arrangement of hydrophobic side chains contributes to the mechanism of selective discrimination between bacterial and eukaryotic membranes. This structural difference is most likely due to the electrostatic interaction between cationic residues closest to the membrane surface (Arg 4 and Arg 6 ) with negatively charged surface head groups of anionic vesicles which embeds the peptide deeper into the micelle, disrupts the interaction of Trp 3 with Ile 7 and causes dislocation of the helix. Interaction of guanidinium groups on arginine residues with phosphate groups of phospholipids has been determined before for PG-1 by solid state NMR and proposed to contribute to the formation of membrane defects [59] . N-terminal proline, which was introduced because of the recombinant peptide production approach was essential for the integrity of the structure and improved the antimicrobial activity. Proline forms an essential part of the hydrophobic cluster, with many side chain contacts with side chains of Phe 2 or Trp
3
. The N-terminal hydrophobic cluster of the PFR peptide has similar function as the short acyl chain of the lipopeptide [60] . The structures in this report can be used to improve the design of more selective peptides by enhancing the differences in local conformational changes caused in zwitterionic and anionic membranes.
